IDENTIFICATION OF PROGNOSTIC SUBGROUPS BY FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES

被引：0
|
作者：
van de Loosdrecht, Arjan [1 ]
Canan, Alhan [1 ]
Ossenkoppele, Gert [1 ]
Westers, Theresia [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands
来源：
CYTOMETRY PART B-CLINICAL CYTOMETRY | 2009年 / 76B卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [21] Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile
    Guarnera, Luca
    Fabiani, Emiliano
    Attrotto, Cristina
    Hajrullaj, Hajro
    Cristiano, Antonio
    Latagliata, Roberto
    Fenu, Susanna
    Buccisano, Francesco
    Irno-Consalvo, Maria
    Conti, Consuelo
    Voso, Maria Teresa
    Maurillo, Luca
    ANNALS OF HEMATOLOGY, 2023, 102 (11) : 3015 - 3023
  • [22] Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact
    Oelschlaegel, Uta
    Oelschlaeger, Lorenz
    von Bonin, Malte
    Kramer, Michael
    Sockel, Katja
    Mohr, Brigitte
    Wagenfuehr, Lisa
    Kroschinsky, Frank
    Bornhaeuser, Martin
    Platzbecker, Uwe
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (02) : 141 - 150
  • [23] Prognostic relevance of cytogenetic subgroups in 357 patients with myelodysplastic syndromes.
    Haase, D
    Schanz, J
    Wulich, J
    Schoch, C
    Freund, M
    Haferlach, T
    Wormann, B
    Staib, P
    Lentini, G
    Bartels, H
    Geissler, RG
    Germing, U
    Dorges, U
    Fonatsch, C
    Hiddemann, W
    BLOOD, 1997, 90 (10) : 2232 - 2232
  • [24] The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex
    Mauritzson, N
    Johansson, B
    Rylander, L
    Albin, M
    Strömberg, U
    Billström, R
    Ahlgren, T
    Mikoczy, Z
    Mitelman, F
    Hagmar, L
    Nilsson, PG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) : 347 - 356
  • [25] Machine Learning Approach Identifies Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS)
    Oelschlaegel, Uta
    Blighe, Kevin
    Winter, Susann
    Sockel, Katja
    Bornhaeuser, Martin
    Kordasti, Shahram
    Platzbecker, Uwe
    BLOOD, 2019, 134
  • [26] Flow cytometry in myelodysplastic syndromes: Ready for translation into clinical practice
    van de Loosdrecht, Arjan A.
    Westers, Theresia M.
    LEUKEMIA RESEARCH, 2011, 35 (07) : 850 - 852
  • [27] Application of Flow Cytometry for Myelodysplastic Syndromes: Pitfalls and Technical Considerations
    Alhan, Canan
    Westers, Theresia M.
    Cremers, Eline M. P.
    Cali, Claudia
    Ossenkoppele, Gert J.
    van de Loosdrecht, Arjan A.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (04) : 358 - 367
  • [28] Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes
    Vikentiou, Myrofora
    Psarra, Katerina
    Kapsimali, Violetta
    Liapis, Konstantinos
    Michael, Michalis
    Tsionos, Konstantinos
    Lianidou, Evi
    Papasteriades, Chryssa
    LEUKEMIA & LYMPHOMA, 2009, 50 (03) : 401 - 409
  • [29] FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES. DEFINITIONS AND CLINICAL APPLICATIONS
    van de Loosdrecht, Arjan A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 : 37 - 38
  • [30] Diagnostic flow cytometry for low-grade myelodysplastic syndromes
    Ogata, Kiyoyuki
    HEMATOLOGICAL ONCOLOGY, 2008, 26 (04) : 193 - 198
12345